8.31
-0.21
(-2.52%)
At close: 4:00:00 PM EDT
8.31
0.00
(0.00%)
After hours: 5:54:44 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | 985.33k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 5.91M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.4 | -0.31 | -0.25 | -0.25 |
| EPS Actual | -0.25 | -0.26 | -0.24 | -0.36 |
| Difference | 0.15 | 0.05 | 0.01 | -0.11 |
| Surprise % | 36.71% | 15.22% | 5.26% | -42.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVCT | -- | -- | -- | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Initiated | Maxim Group: Buy | 4/2/2025 |
| Initiated | Laidlaw & Co.: Buy | 3/17/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/15/2023 |
Related Tickers
PRQR ProQR Therapeutics N.V.
1.1200
-0.88%
XTLB XTL Biopharmaceuticals Ltd.
1.1250
-3.85%
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%
ETNB 89bio, Inc.
5.53
+10.71%
NUVL Nuvalent, Inc.
66.29
+6.94%
CRVS Corvus Pharmaceuticals, Inc.
2.9800
+3.83%
GYRE Gyre Therapeutics, Inc.
7.52
+3.16%
SRZN Surrozen, Inc.
9.00
0.00%
TRVI Trevi Therapeutics, Inc.
5.56
+5.30%
MDNAF Medicenna Therapeutics Corp.
0.6500
+0.78%